Option Care Health Inc(OPCH) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 30 at 4:15 PM ET (Korea 10/31 05:15)
Full metrics table
| Index | RUT | P/E | 24.08 | EPS (ttm) | 1.32 | Insider Own | 1.76% | Shs Outstand | 149.8M | Perf Week | 1.95% |
| Market Cap | 4.77B | Forward P/E | 15.28 | EPS next Y | 10.71% | Insider Trans | 3.51% | Shs Float | 147.2M | Perf Month | 40.97% |
| Enterprise Value | 5.84B | PEG | 1.45 | EPS next Q | 0.49 | Inst Own | 106.92% | Short Float | 4.84% | Perf Quarter | 34.3% |
| Income | 0.21B | P/S | 0.84 | EPS this Y | 9.38% | Inst Trans | -39.76% | Short Ratio | 1.82 | Perf Half Y | 58.91% |
| Sales | 5.69B | P/B | 3.78 | EPS next 5Y | 10.52% | ROA | 6.2% | Short Interest | 7.12M | Perf YTD | -0.09% |
| Book/sh | 8.41 | P/C | 24.61 | EPS past 3/5Y | 15.4% - | ROE | 16% | 52W High | -13.51% ($36.80) | Perf Year | 21.47% |
| Cash/sh | 1.29 | P/FCF | 15.69 | Sales past 3/5Y | 12.72% 13.25% | ROIC | 8.39% | 52W Low | 76.74% ($18.01) | Perf 3Y | 18.64% |
| Dividend Est. | - | EV/EBITDA | 14.42 | EPS Y/Y TTM | 5.33% | Gross Margin | 17.87% | Volatility(W/M) | 0.42% 0.66% | Perf 5Y | 16.47% |
| Dividend TTM | - | EV/Sales | 1.03 | Sales Y/Y TTM | 5.95% | Oper. Margin | 5.86% | ATR (14) | 0.41 | Perf 10Y | 188.32% |
| Dividend Ex-Date | - | Quick Ratio | 0.98 | EPS Q/Q | 14.13% | Profit Margin | 3.68% | RSI (14) | 84.25 | Recom | 2.92 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.47 | Sales Q/Q | 1.86% | SMA20 | 3.16% ($30.85) | Beta | 0.53 | Target Price | $30.03 |
| Payout | - | Debt/Eq | 1.01 | Earnings | 2026/11/4 | SMA50 | 20.07% ($26.51) | Rel Volume | 1.08 | Prev Close | $31.85 |
| Employees | 6528 | LT Debt/Eq | 0.98 | EPS/Sales Surpr. | 5.56% 1.6% | SMA200 | 20.92% ($26.32) | Avg Volume(3M) | 3.92M | Price | $31.83 |
| IPO | 1996/8/15 | Option/Short | Yes/Yes | Trades | 11491 | Volume | 4,228,346 | Change | -0.06% |
💉 This is a U.S. healthcare services company that provides home infusion therapy services. It delivers drug compounding and nursing services that allow patients to receive intravenous treatments at home or in non-hospital settings, giving it exposure to demand for the treatment of both chronic and acute conditions. It is a company in the home infusion therapy sector.
Over the past 1 year, roughly in the middle
14% below its 1-year high.
Traded about as much as usual. That is 108% of its average volume.
Next earnings report: November 4
4 days to go.
OPCH makes money exceptionally well
Of every $100 in sales, $5.86 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +9.4% this year.
Tap to view numbers
The price is about the industry average
Counting its debt, for $100 of yearly operating cash you would pay $1,442. Peers typically go for $1,325. It is about in line with its own 5-year average.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have paid off
Bought 5 years ago, your return today would be +16.5%. The S&P 500 did +65% over the same period.
Tap to view numbers
No dividend
It reinvests profits in the business instead of paying dividends.
Ownership looks stable
Institutions hold 106.9%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #12 of 48 in the industry
Based on market cap of $5B.
CHE#9 Chemed Corp $7B PER 25.6 
CON#10 Concentra Group Holdings Parent Inc $5B PER 26.5 
LFST#11 LifeStance Health Group Inc $5B PER 103.1 OPCH#12 Option Care Health Inc $5B PER 24.1 
NHC#13 National Healthcare Corp $3B PER 23.2 
FAQ
What kind of company is OPCH?
OPCH belongs to the Healthcare sector and operates in the Medical Care Facilities industry.
What is the market cap of OPCH?
The market cap of OPCH is approximately $4.8B, ranking 1,403 within its sector.
What is the P/E ratio of OPCH?
OPCH has a P/E ratio of approximately 24.1x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for OPCH?
OPCH has recorded a 52-week high of $36.80 and a low of $18.01.
